Detalles de la búsqueda
1.
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.
Haematologica
; 105(3): 640-651, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278207
2.
[GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME].
Lijec Vjesn
; 139(1-2): 1-11, 2017.
Artículo
en Hr
| MEDLINE | ID: mdl-30148578
3.
[AUTOLOGOUS STEM CELL TRANSPLANTATION IN REFRACTORY OR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA - A SINGLE CENTRE EXPERIENCE]. / AUTOLOGNA TRANSPLANTACIJA PERIFERNIH MATICNIH STANICA U REFRAKTORNOM ILI RELAPSNOM NE-HODGKINOVU LIMFOMU DIFUZNOGA B-VELIKOSTANICNOG TIPA - ISKUSTVO JEDNOG CENTRA.
Lijec Vjesn
; 137(9-10): 276-82, 2015.
Artículo
en Hr
| MEDLINE | ID: mdl-26749949
4.
Successful long-term treatment with azacitidine in patient with chronic myelomonocytic leukemia.
Hematol Rep
; 12(3): 8537, 2020 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33324479
5.
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.
Blood Adv
; 2(16): 2079-2089, 2018 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30126931
6.
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.
Leuk Res
; 67: 21-26, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29407183
Resultados
1 -
6
de 6
1
Próxima >
>>